IP Library Granted Patent US 10,036,012
Granted Patent B2
US 10,036,012 · App. 15/471,785 · Granted Jul 31, 2018

Compositions and methods for targeted nucleic acid sequence enrichment and high efficiency library generation

Inventors: Doug Amorese (Los Altos, CA); Chris Armour (Kirkland, WA); Nurith Kurn (Palo Alto, CA)
Assignee: NUGEN TECHNOLOGIES, INC.
C12N15/1068C12N15/1072C12N15/66C12Q2525/191
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,036,012
App. No.
15/471,785
Granted
Jul 31, 2018
Kind
B2
Abstract

The present invention provides methods, compositions and kits for targeted nucleic acid sequence enrichment in a nucleic acid sample and for high efficiency nucleic acid library generation for next generation sequencing (NGS). Specifically, the methods, compositions and kits provided herein are useful for the production and capture of amplification-ready, target-specific and strand-specific regions of interest from nucleic acid samples containing complex DNA.

Claims (28)

1. A method for sequencing an enriched nucleic acid sequence of interest, the method comprising:

a) obtaining a nucleic acid fragment ligated to a partial duplex adaptor, wherein the nucleic acid fragment comprises a nucleic acid sequence of interest, wherein the partial duplex adaptor comprises a first adaptor sequence, and wherein the partial duplex adaptor comprises a first strand and a second strand, wherein the first strand is longer than the second strand;

b) annealing one or more oligonucleotides in solution to the nucleic acid sequence of interest in the nucleic acid fragment ligated to the partial duplex adaptor, wherein the one or more oligonucleotides comprise a 3′ portion with at least 10 bases designed to be complementary to the nucleic acid sequence of interest and a 5′ tail portion comprising a second adaptor sequence that is non-complementary to the nucleic acid sequence of interest;

c) extending the one or more oligonucleotides annealed to the nucleic acid sequence of interest in the nucleic acid fragment ligated to the partial duplex adaptor with a polymerase, thereby generating one or more oligonucleotide extension products comprising sequence complementary to the first adaptor sequence at a first end, sequence complementary to the nucleic acid sequence of interest, and the second adaptor sequence at a second end;

d) amplifying the one or more oligonucleotide extension products using a first primer that anneals to a complement of the first adaptor sequence and a second primer that anneals at its 3′ end to a complement of the second adaptor sequence to enrich for the nucleic acid sequence of interest, wherein products of the amplifying comprise a 3′ end with sequence complementary to a sequence on a surface;

e) annealing a strand of the products of the amplifying to the sequence on the surface using the 3′ end with sequence complementary to the sequence on the surface; and

f) sequencing the enriched nucleic acid sequence of interest on a massively parallel sequencing platform.

2. The method of claim 1 , wherein the nucleic acid fragment comprises genomic DNA.

3. The method of claim 1 , wherein the nucleic acid fragment comprises cDNA.

4. The method of claim 1 , wherein the nucleic acid fragment comprises RNA.

5. The method of claim 1 , wherein the first adaptor sequence and the second adaptor sequence are distinct from each other.

6. The method of claim 1 , wherein the one or more oligonucleotides comprise more than one oligonucleotide, and wherein the second adaptor sequence is common to the more than one oligonucleotides.

7. The method of claim 1 , wherein the first adaptor sequence, the second adaptor sequence, or both comprise barcode sequence.

8. The method of claim 7 , wherein the barcode sequence is at least 8 nucleotides in length.

9. The method of claim 7 , wherein the barcode sequence is 12 nucleotides in length.

10. The method of claim 1 , wherein the obtaining comprises obtaining a plurality of nucleic acid fragments ligated to a partial duplex adaptor, wherein each partial duplex adaptor of each nucleic acid fragment of the plurality of nucleic acid fragments comprises a barcode, and wherein each barcode is unique.

11. The method of claim 1 , wherein the nucleic acid fragment ligated to the partial duplex adaptor is double-stranded prior to step b).

12. The method of claim 11 , further comprising denaturing the nucleic acid fragment ligated to the partial duplex adaptor prior to step b), thereby generating a single-stranded nucleic acid fragment comprising the nucleic acid sequence of interest ligated to the first adaptor sequence.

13. The method of claim 1 , wherein the polymerase is a DNA polymerase.

14. The method of claim 1 , wherein the first strand of the partial duplex adaptor is ligated to a 5′ end of the nucleic acid fragment.

15. The method of claim 1 , wherein the second strand of the partial duplex adaptor is ligated to a 3′ end of the nucleic acid fragment.

16. The method of claim 1 , further comprising fragmenting a nucleic acid, thereby generating a nucleic acid fragment; and purifying the nucleic acid fragment prior to obtaining the nucleic acid fragment ligated to the partial duplex adaptor in step a).

17. The method of claim 1 , further comprising performing bridge amplification of the annealed strand after step e).

18. The method of claim 1 , wherein the sequencing comprises use of four labeled reversible terminators.

19. The method of claim 1 , wherein the sequencing comprises semiconductor sequencing.

20. The method of claim 1 , further comprising fragmenting a nucleic acid, thereby generating a nucleic acid fragment; and performing end repair on the nucleic acid fragment prior to obtaining the nucleic acid fragment ligated to the partial duplex adaptor in step a).

21. The method of claim 1 , wherein the nucleic acid fragment of the nucleic acid fragment ligated to the partial duplex adaptor in step a) is obtained by performing reverse transcription on an RNA fragment prior to obtaining the nucleic acid fragment ligated to the partial duplex adaptor in step a).

22. The method of claim 1 , wherein each end of the nucleic acid fragment is ligated to a partial duplex adaptor.

Assignments (2)
CHANGE OF NAME Recorded Aug 28, 2023
From: NUGEN TECHNOLOGIES, INC.
To: TECAN GENOMICS, INC.
Reel/Frame 064742/0042 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 7, 2017
From: AMORESE, DOUG; ARMOUR, CHRIS; KURN, NURITH
To: NUGEN TECHNOLOGIES, INC.
Reel/Frame 044327/0953 →
Continuity (3)
Continuation 13750768 · Jan 25, 2013
Provisional Application 61591241 · Jan 26, 2012
Related Publication 20170298345A1 · Oct 19, 2017
Cited By (6)
US 12,371,732 US 12,492,430 US 12,492,435 US 12,522,857 US 12,600,963 US 12,630,864